Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Keyphrases

• Scotland 100%
• Thrombocytopenia 100%
• Hemorrhagic Disease 100%
• ChAdOx1 100%
• BNT162b2 COVID-19 Vaccine 100%
• Second Dose 100%
• Thrombotic Thrombocytopenic Purpura 50%
• Confidence Interval 37%
• Incidence Rate 37%
• Risk Periods 25%
• BNT162b2 25%
• Vaccination 12%
• Risk Profile 12%
• Further Analysis 12%
• Case Series Analysis 12%
• Self-controlled Case Series 12%
• BNT162b2 Vaccine 12%
• ChAdOx1 Vaccine 12%
• Reassurance 12%
• Two-dose 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Thromboembolism 100%
• COVID-19 Vaccine 100%
• Idiopathic Thrombocytopenic Purpura 100%
• Vaccination Policy 50%

Biochemistry, Genetics and Molecular Biology

• Reassurance 25%